Croda creates long-term value by engaging with our customers and markets wherever and whenever they need us - creating, making and selling sustainable and innovative speciality ingredients. We call this Smart science to improve lives™.Find out more
We provide practical solutions to help address some of the world’s biggest challenges and are committed to becoming the most sustainable supplier of innovative ingredients. As part of this we will become Climate, Land and People Positive by 2030, having used the United Nations Sustainable Development Goals (SDGs) to underpin our approach.
This section tells you more about our goals, how we are achieving them, and the successes we have already achieved.
Contact Croda investor relations
Please contact our Investor Relations team by email
Individual shareholder queries are dealt with by our Registrars, Link Asset Services. Contact details can be found in our shareholder information centre.
Case study: Improving the customer experience in China
Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.
The self-service website means customers in China can request product information and samples quickly and easily. This project demonstrates our commitment to invest in digital: using the latest technology to enhance visibility, engagement and service to customers. Building local expertise and adapting terminology, language and content to resonate with a Chinese audience brings new opportunities to reach customers in more remote locations in China that would otherwise be difficult to visit in person. Technology like this will continue shaping how we engage, interact and serve our customers.
Sustainability expert Aris Vrettos joins Croda
The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...Read more
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.Read more
U.S. Government to support expansion of Croda lipid systems capability
Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccinesRead more